A difference‐in‐differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening
Cancer · 2025
DOI: 10.1002/cncr.35904 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Jim P Stimpson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics, Systems, and Policy, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Sick Leave, Medicaid, Early Detection of Cancer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Cancer Society.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) screening disparities persist among populations with limited health care access. Although Medicaid expansion and paid sick leave could address these barriers, there is limited data on the combined impact of these policies and CRC screening.
Methods
The authors conducted a difference‐in‐differences analysis using 2012–2018 Behavioral Risk Factor Surveillance System data. The study population included adults 50–75 years of age meeting preventive cancer screening guidelines during the study period. States were categorized into three groups: those with Medicaid expansion and paid sick leave (ME + SL), Medicaid expansion without paid sick leave (MEnoSL), and neither policy (NoME/NoSL). The pre‐policy period was 2012–2014 and the post‐policy period was 2015–2018. The outcome was the percent up‐to‐date with CRC screening. Survey‐weighted logistic regression models accounted for individual‐ and state‐level covariates and state‐clustered standard errors.
Results
Post‐policy implementation, CRC up‐to‐date screening was 2.9 percentage points greater in ME + SL states compared to MEnoSL states ( p < .001) and 4.2 percentage points greater compared to NoME/NoSL states ( p = .018). These changes correspond to an estimated 352,343 and 1,087,140 fewer missed screenings between ME + SL and MEnoSL and NoME/NoSL states, respectively. The increased percent of up‐to‐date CRC screenings was associated with a reduction in colorectal cancer deaths: 8456 from ME + SL versus MEnoSL and 26,091 from ME + SL versus NoME/NoSL.
Conclusions
Medicaid expansion combined with paid sick leave was associated with a greater likelihood of being up‐to‐date with CRC screening compared to Medicaid expansion alone or neither policy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Economics, Systems, and Policy, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Medicine, University of Arizona, Tucson, Arizona, USA.
- Department of Medicine, University of Washington, Seattle, Washington, USA.
- Matheson Center for Health Care Studies, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Jim P Stimpson, Joseph H Joo
Förderung
- American Cancer Society
Zitieren
APA
Stimpson, J. P., Liao, J. M., Morenz, A. M., Joo, J. H., & Wilson, F. A. (2025). A difference‐in‐differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening. Cancer. https://doi.org/10.1002/cncr.35904
Vancouver
Stimpson JP, Liao JM, Morenz AM, Joo JH, Wilson FA. A difference‐in‐differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening. Cancer. 2025. doi:10.1002/cncr.35904
BibTeX
@article{Stimpson2025,
author = {Stimpson, Jim P and Liao, Joshua M and Morenz, Anna M and Joo, Joseph H and Wilson, Fernando A},
title = {A difference‐in‐differences analysis of Medicaid expansion and state paid sick leave laws on colorectal cancer screening},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35904}
}
EUVIMED